Roche Finance Ltd 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-07 5:16 pm Purchase |
2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS |
Roche Finance Ltd | 441,038 15.350% |
317,344 (+256.56%) |
Filing |
| 2021-02-16 07:03 am Purchase |
2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Roche Finance Ltd | 123,694 8.100% |
123,694 (New Position) |
Filing |